Abstract:Objective: To identify the factors associated with long-term survival and guide the decision for primary surgery in patients with advanced high-grade serous ovarian cancer(HGSOC). Methods: In this case-control study, clinical parameters, including surgical and non-surgical associated factors, were collected and compared between the patients with short-term (<2 years) and long-term (>5 years) survival who all underwent primary debulking surgery (PDS) followed by carboplatin and paclitaxel chemotherapy from January 2004 to December 2016. Univariate analysis was examined by chi-square test and multivariate analysis was performed by logistic regression analysis. Results: There were 95 cases long-term survival (LTS group) and 77 cases short-term survival (STS group) in 698 newly diagnosed HGSOC patients with International Federation of Gynecology and Obstetrics (FIGO) stage Ⅲc and Ⅳ who met include and exclude criteria. (1) Univariate analysis showed that the proportion of complete cytoreduction with no visible residual disease (R0) at PDS and platinum sensitivity in LTS group were significantly higher than those in STS group (P<0.01). The surgical complexity score (SCS), the preoperative serum CA125 level and the ascites volume in the LTS group were significantly lower than those of the STS group (all P<0.05). In the LTS group, the preoperative incidence of lesions in retrograde peritoneum of the bladder, serosal and mesangial membrane of the small intestine, upper abdominal peritoneum and liver parenchyma were significantly lower than those in the STS group (all P<0.05). Multivariate logistic regression analysis showed that platinum sensitivity (OR=0.016, 95%CI: 0.004-0.063, P<0.01), ascites volume >500 ml (OR=3.193, 95%CI: 1.285-7.930, P=0.012), and SCS ≥8 (OR=17.433, 95%CI: 2.281-133.25, P=0.003) were independent factors affecting long-term survival (P>0.05). (2) Totally 37 of 95 in long-term survival and 16 of 77 in short-term survival achieved R0 cytoreduction at PDS. Univariate analysis showed that preoperative serum CA125 level, preoperative lesion score, preoperative lesion (DS) score, ascites volume, platinum sensitivity,and SCS were significantly correlated with the R0 PDS (all P<0.05). Multivariate analysis showed that ascites volume >500 ml (OR=5.199, 95%CI: 2.015-13.409, P=0.001), DS >2 (OR=15.264, 95%CI: 5.843-39.874, P<0.01) and SCS ≥4 (OR=4.176, 95%CI: 1.618-10.777, P=0.003) were independent factors associated with R0 cytoreduction. In patients with DS ≤2 or SCS <4, but not those with DS >2 or SCS ≥4, R0 cytoreduction was significantly associated with long-term survival. Conclusion: The intrinsic biology of tumor is the factor influencing long-term survival of advanced HGSOC patients, and those who present with wide intraperitoneal metastases and need to remove multiple organs may not benefit from R0 cytoreduction.

Patient Selection for Surgery for Peritoneal Sarcomatosis in Retroperitoneal Sarcoma —— External Validation of the Simplified Peritoneal Sarcomatosis Score

Macroscopically Complete Excision is a Beneficial Strategy for Selected Patients with Peritoneal Sarcomatosis.

Multidimensional characteristics, prognostic role, and preoperative prediction of peritoneal sarcomatosis in retroperitoneal sarcoma

Survival and prognostic factors of primary retroperitoneal sarcomas after surgery: a single-center experience

What Influences the Long-Term Survival of Advanced High-Grade Serous Ovarian Cancer?

Survival Outcomes of Surgery for Retroperitoneal Sarcomas: A Systematic Review and Meta-Analysis

Treatment algorithm and surgical outcome for primary and recurrent retroperitoneal sarcomas: A long-term single-center experience of 242 cases

Influence of nutritional status and body composition on postoperative events and outcome in patients treated for primary localized retroperitoneal sarcoma

Radical Versus Non-Radical Resection for Early-Stage Retroperitoneal Sarcoma: A Propensity Score-Matched Analysis

Longitudinal and time-to-event modeling for prognostic implications of radical surgery in retroperitoneal sarcoma

Development and validation of a nomogram for predicting morbidity in surgically resected primary retroperitoneal sarcoma

Prognostic factors of primary resected retroperitoneal soft tissue sarcoma: Analysis from a single asian tertiary center and external validation of gronchi's nomogram.

Prognostic Factors of Retroperitoneal Soft Tissue Sarcomas: Analysis of 132 Cases

Tumor Grade and Symptoms at Presentation Are Survival Risk Factors in Chinese Patients with Primary Retroperitoneal Sarcoma.

Retroperitoneal soft tissue sarcomas: Predictive factors for incomplete resection

Sarcopenia is Associated with Worse Surgical Complications but Not Relapse-Free Survival and Overall Survival in Patients with Retroperitoneal Liposarcoma

Patients with First Recurrent Retroperitoneal Sarcoma That Can Be Macroscopically Completely Resected Can Achieve Comparable Outcomes with That of Primary Patients after En Bloc Resection of Tumor and Adjacent Organs

Short‐ and Long‐term Surgical Outcomes of Pancreatic Resection for Retroperitoneal Sarcoma: A Long‐term Single‐center Experience of 90 Cases

Resection Outcomes for Primary and Local Recurrent Retroperitoneal Liposarcoma Patients

Does Aggressive Surgery Mean Worse Quality of Life and Functional Capacity in Retroperitoneal Sarcoma Patients?—A Retrospective Study of 161 Patients from China

Aggressive Surgical Approach with Vascular Resection and Reconstruction for Retroperitoneal Sarcomas: a Systematic Review